Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CLRB Cellectar Biosciences Inc.

盘后交易 03-16 16:36:14 EDT

3.27

+0.07

+2.19%

盘后3.27

+0.000.00%

16:10 EDT

最高3.40	最低3.11	成交量4.28万
今开3.26	昨收3.20	日振幅9.06%
总市值1,387万	流通市值1,327万	总股本424.01万
成交额14.03万	换手率1.05%	流通股本405.90万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences Inc.","latestPrice":3.27,"timestamp":1773691200000,"preClose":3.2,"halted":0,"volume":42760,"hourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.27,"latestTime":"16:10 EDT","volume":6,"amount":19.62,"timestamp":1773691804720,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02187499999999995,"floatShares":4059000,"shares":4240134,"eps":-8.354443,"marketStatus":"盘后交易","change":0.07,"latestTime":"03-16 16:36:14 EDT","open":3.26,"high":3.4,"low":3.11,"amount":140282.17612,"amplitude":0.090625,"askPrice":3.54,"askSize":100,"bidPrice":2.91,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.354443,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773705600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.2,"preHourTrading":{"tag":"盘前","latestPrice":3.2,"preClose":3.2,"latestTime":"09:25 EDT","volume":357,"amount":1144.188213,"timestamp":1773667513270,"change":0,"changeRate":0,"amplitude":0.034937},"postHourTrading":{"tag":"盘后","latestPrice":3.27,"preClose":3.27,"latestTime":"16:10 EDT","volume":6,"amount":19.62,"timestamp":1773691804720,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.514185,"impliedVol":1.1856,"impliedVolPercentile":0.8841},"requestUrl":"/m/hq/s/CLRB","defaultTab":"news","newsList":[{"id":"2616755321","title":"Cellectar Biosciences, Inc.盘中异动 大幅下跌7.86%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616755321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616755321?lang=zh_cn&edition=full","pubTime":"2026-03-03 01:50","pubTimestamp":1772473800,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日01时50分，Cellectar Biosciences, Inc.股票出现异动，股价急速下挫7.86%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Rallybio Corporation、Anebulo Pharmaceuticals, Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Rallybio Corporation较为活跃，换手率分别为154.43%、92.51%、53.62%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Anebulo Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为53.84%、38.89%、31.86%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603030150009542a753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603030150009542a753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4123","PDC","CLRB","BK4139"],"gpt_icon":0},{"id":"2614867148","title":"Cellectar Biosciences, Inc.盘中异动 急速下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614867148?lang=zh_cn&edition=full","pubTime":"2026-02-28 00:29","pubTimestamp":1772209796,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日00时29分，Cellectar Biosciences, Inc.股票出现异动，股价快速下跌5.41%。截至发稿，该股报3.32美元/股，成交量5520股，换手率0.13%，振幅3.99%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Ensysce Biosciences, Inc.、Edesa Biotech, Inc.、Neurogene Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为6195.78%、555.22%、224.13%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Edesa Biotech, Inc.、Ensysce Biosciences, Inc.，振幅分别为76.88%、60.64%、51.85%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022800295695424d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022800295695424d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PDC","CLRB","BK4123"],"gpt_icon":0},{"id":"2610667714","title":"Cellectar Biosciences, Inc.盘中异动 快速拉升5.26%报3.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610667714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610667714?lang=zh_cn&edition=full","pubTime":"2026-02-10 01:35","pubTimestamp":1770658515,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日01时35分，Cellectar Biosciences, Inc.股票出现异动，股价大幅上涨5.26%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Moolec Science Sa C/Wts 30/01/2028、Humacyte, Inc.、Tuhura Biosciences, Inc.涨幅较大，Agomab Therapeutics Nv、Liminatus Pharma, Inc.、Aim Immunotech Inc.较为活跃，换手率分别为325.30%、181.27%、29.54%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.，振幅分别为59.15%、52.99%、51.63%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210013516a6e6fa5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210013516a6e6fa5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139","PDC","BK4123"],"gpt_icon":0},{"id":"2603549630","title":"Cellectar Biosciences, Inc.盘中异动 临近午盘急速上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603549630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603549630?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:39","pubTimestamp":1768322398,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日00时39分，Cellectar Biosciences, Inc.股票出现波动，股价急速拉升6.58%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Xtl生物制药、Decoy Therapeutics Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Decoy Therapeutics Inc.、Scisparc Ltd.、Briacell Therapeutics Corp.较为活跃，换手率分别为1406.61%、1178.14%、338.44%，振幅较大的相关个股有Xtl生物制药、Lexaria Bioscience Corp C/Wts 14/01/2026 、Decoy Therapeutics Inc.，振幅分别为96.62%、67.92%、41.72%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114003959953ca0d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114003959953ca0d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1136702473","title":"Cellectar Biosciences Inc. 将重点阐述2026年战略规划","url":"https://stock-news.laohu8.com/highlight/detail?id=1136702473","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136702473?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:47","pubTimestamp":1767966468,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Inc. 计划在即将于第44届摩根大通医疗健康大会期间举办的生物技术展示会上，重点阐述其2026年的战略举措。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","BK4566","IE00BN8TJ469.HKD","LU0942090050.USD","LU1496350502.SGD","IE00BKDWB100.SGD","LU2552382058.USD","IE00BHPRN162.USD","IE0034235295.USD","IE00BBT3K403.USD","LU2213496289.HKD","IE00BYXW3230.USD","LU2592432038.USD","IE00BJLML261.HKD","IE00BDCRKT87.USD","LU1244550494.USD","LU0345769128.USD","LU0964807845.USD","LU1914381329.SGD","LU0211327993.USD","IE00B3S45H60.SGD","LU1894683264.USD","LU0417517546.SGD","LU2357305700.SGD","LU0689472784.USD","LU1280957306.USD","BK4504","LU2023250330.USD","IE00BJTD4V19.USD","SG9999002232.USD","LU0943347566.SGD","LU0211326839.USD","CLRB","LU0310799852.SGD","LU2237443465.HKD","LU0170899867.USD","IE0034235303.USD","IE00BFXG1179.USD","LU0211331839.USD","LU2236285917.USD","LU2756315318.SGD","LU0203347892.USD","LU0345770993.USD","LU0496365809.HKD","LU2417539215.USD","IE00BKVL7J92.USD","LU0683600562.USD","LU1988902786.USD","LU1064131342.USD","LU1244550221.USD","LU0006306889.USD","JPM","IE00B1XK9C88.USD","LU1116320737.USD","LU2456880835.USD","LU0882574139.USD","IE00BLSP4239.USD","BK4516","LU0149725797.USD","LU2430703251.USD","LU1629891620.HKD","BK4581","IE00BJTD4N35.SGD","LU2505996681.GBP","LU0971096721.USD","LU0868494617.USD","LU0208291251.USD","LU1894683348.USD","LU2237443978.SGD","LU0640476718.USD","LU0211326755.USD","LU0215105999.USD","IE00B1BXHZ80.USD","LU0251132253.USD","LU0976567544.SGD","LU2237443895.HKD","LU2505996509.AUD","LU2430703178.SGD","LU1974910355.USD","LU2264538146.SGD","LU1032466523.USD","LU0820562030.AUD","IE00B775SV38.USD","LU0345770308.USD","LU1145028129.USD","LU0070302665.USD","LU1496350171.SGD","LU2237443622.USD","LU0238689110.USD","LU0868494708.USD","LU2430703095.HKD","LU2746668461.USD","IE00BZ1G4Q59.USD","LU1261432733.SGD","LU0203345920.USD","IE00BDRTCR15.USD","LU0048584097.USD","LU1720051108.HKD","LU2552382132.HKD","LU0234572021.USD","LU1116320901.HKD","IE0034235188.USD","LU1366192091.USD","LU2756315664.SGD","LU1267930490.SGD","BK4588","LU0345769631.USD","LU2746668974.SGD","LU0320765489.SGD","LU1551013342.USD","LU2381873111.SGD","LU0267386448.USD","LU1244550577.SGD","LU0787776722.HKD","LU0820561909.HKD","LU2023250504.SGD","BK4585","BK4533","LU2237443382.USD","LU2211815571.USD","BK4139","BK4534","IE00BLSP4452.SGD","LU1670627923.USD","LU0106261372.USD","LU0106831901.USD","LU2054465674.USD","LU1551013425.SGD","IE00BWXC8680.SGD","LU1548497426.USD","LU1720051017.SGD","LU0211328371.USD","LU0820561818.USD","IE000M9KFDE8.USD","LU2242649171.HKD","LU1668664300.SGD","LU2552382215.SGD","LU0323591593.USD","LU2023250843.SGD","LU1084165304.USD","BK4550","LU1917777945.USD","LU0256863811.USD","SG9999002224.SGD","LU1119994496.HKD","LU1363072403.SGD","LU0320765646.SGD","LU1670628061.USD","LU2106854487.HKD","LU2237443549.SGD","LU0265550946.USD","LU1162221912.USD","LU0265550359.USD","BK4207"],"gpt_icon":0},{"id":"2593068469","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.22%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593068469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593068469?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:32","pubTimestamp":1766413947,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时32分，Cellectar Biosciences, Inc.股票出现异动，股价大幅拉升5.22%。截至发稿，该股报2.82美元/股，成交量4009股，换手率0.09%，振幅0.37%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Equillium, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Gt Biopharma, Inc.较为活跃，换手率分别为112.94%、15.79%、8.77%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Aligos Therapeutics, Inc.、Ovid Therapeutics Inc.，振幅分别为9.31%、8.52%、8.16%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223227a6c1e905&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223227a6c1e905&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"1161773292","title":"Cellectar Biosciences与Ionetix达成战略供货协议，以推进靶向α疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1161773292","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161773292?lang=zh_cn&edition=full","pubTime":"2025-12-16 21:06","pubTimestamp":1765890371,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences与Ionetix达成战略供货协议，提供铀-225和砝-211，以推进靶向α疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2584992567","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584992567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584992567?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:32","pubTimestamp":1763476340,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时32分，Cellectar Biosciences, Inc.股票出现波动，股价急速上涨5.14%。截至发稿，该股报3.07美元/股，成交量5361股，换手率0.13%，振幅3.08%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Clearmind Medicine Inc.涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为957.02%、482.47%、265.99%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为46.48%、16.40%、14.20%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223220a7022478&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223220a7022478&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1159984688","title":"Cellectar Biosciences因Iopofosine I 131在复发或难治性儿童高等级胶质瘤中获得美国食品药品管理局的稀有儿童疾病认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1159984688","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159984688?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:30","pubTimestamp":1761568216,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences因Iopofosine I 131在复发或难治性儿童高等级胶质瘤中获得美国食品药品管理局的稀有儿童疾病认定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1128034086","title":"Cellectar Biosciences：Iopofosine I 131有望于2027年在欧洲获批并商业化上市，用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症","url":"https://stock-news.laohu8.com/highlight/detail?id=1128034086","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128034086?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:03","pubTimestamp":1759748624,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences：Iopofosine I 131有望于2027年在欧洲获批并商业化上市，用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1143563709","title":"Cellectar Biosciences宣布欧洲药品管理局确认其符合条件，可为Iopofosine I 131申请有条件上市许可，用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症","url":"https://stock-news.laohu8.com/highlight/detail?id=1143563709","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143563709?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:02","pubTimestamp":1759748538,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences宣布，欧洲药品管理局已确认该公司符合条件，可为其药物Iopofosine I 131申请有条件上市许可，该药物用于治疗难治性（BTK抑制剂治疗后）华氏巨球蛋白血症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"1137012450","title":"Cellectar Biosciences与Evestia Clinical宣布建立合作关系，共同推进三阴性乳腺癌俄歇电子发射放射性药物临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1137012450","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137012450?lang=zh_cn&edition=full","pubTime":"2025-09-24 20:30","pubTimestamp":1758717020,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences与Evestia Clinical宣布建立合作关系，共同推进三阴性乳腺癌俄歇电子发射放射性药物临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2568623163","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.73%报5.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568623163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568623163?lang=zh_cn&edition=full","pubTime":"2025-09-18 22:00","pubTimestamp":1758204059,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日22时00分，Cellectar Biosciences, Inc.股票出现异动，股价快速上涨5.73%。截至发稿，该股报5.35美元/股，成交量4789股，换手率0.15%，振幅3.16%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，89Bio, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.涨幅较大，Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃，换手率分别为2174.70%、1039.36%、278.25%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cdt Equity Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.，振幅分别为52.69%、31.75%、31.72%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918220100979b30ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918220100979b30ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2518224030","title":"Cellectar Biosciences, Inc.盘中异动 大幅上涨5.79%报0.336美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518224030?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:38","pubTimestamp":1741613933,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时38分，Cellectar Biosciences, Inc.股票出现异动，股价大幅上涨5.79%。截至发稿，该股报0.336美元/股，成交量29.5357万股，换手率0.64%，振幅5.53%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为482.63%、74.60%、55.47%，振幅较大的相关个股有Seer, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为98.72%、34.57%、25.80%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021385398a29e82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021385398a29e82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2517167845","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.37%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517167845?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:09","pubTimestamp":1741277382,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时09分，Cellectar Biosciences, Inc.股票出现异动，股价大幅上涨5.37%。截至发稿，该股报0.320美元/股，成交量22.5693万股，换手率0.49%，振幅7.28%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000942a262a80a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000942a262a80a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2517677945","title":"Cellectar Biosciences, Inc.盘中异动 早盘大幅上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517677945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517677945?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:00","pubTimestamp":1741186827,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时00分，Cellectar Biosciences, Inc.股票出现波动，股价快速拉升5.26%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为722.68%、276.27%、237.00%，振幅较大的相关个股有Nkgen Biotech, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Silexion Therapeutics Corp，振幅分别为40.77%、36.89%、33.33%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230027abe9ba43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305230027abe9ba43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2516637894","title":"Cellectar Biosciences, Inc.盘中异动 早盘股价大涨5.08%报0.304美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637894?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:47","pubTimestamp":1741013272,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时47分，Cellectar Biosciences, Inc.股票出现异动，股价快速拉升5.08%。截至发稿，该股报0.304美元/股，成交量10.2894万股，换手率0.22%，振幅2.73%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Geovax Labs, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为346.65%、109.40%、66.34%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为140.46%、68.30%、24.83%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032247529637b100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032247529637b100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2514850662","title":"Cellectar Biosciences, Inc.盘中异动 大幅拉升5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514850662?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:40","pubTimestamp":1740588037,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时40分，Cellectar Biosciences, Inc.股票出现波动，股价快速上涨5.57%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5929.07%、215.68%、215.55%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Organovo Holdings, Inc.，振幅分别为181.36%、49.18%、43.31%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270040379893c314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270040379893c314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CLRB"],"gpt_icon":0},{"id":"2514905560","title":"Cellectar Biosciences, Inc.盘中异动 股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514905560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514905560?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493879,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Cellectar Biosciences, Inc.股票出现异动，股价大幅上涨5.46%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为748.35%、529.64%、461.94%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Maze Therapeutics, Inc.，振幅分别为43.36%、19.20%、8.87%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522312098924c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522312098924c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0},{"id":"2514705674","title":"Cellectar Biosciences, Inc.盘中异动 临近收盘股价大跌5.56%报0.294美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705674?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:57","pubTimestamp":1740430678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时57分，Cellectar Biosciences, Inc.股票出现异动，股价急速下跌5.56%。截至发稿，该股报0.294美元/股，成交量65.8749万股，换手率1.43%，振幅4.98%。Cellectar Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为333.01%、145.74%、41.82%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、164.23%、81.92%。Cellectar Biosciences, Inc.公司简介：Cellectar Biosciences Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045759a2526493&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045759a2526493&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLRB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cellectar.com","stockEarnings":[{"period":"1week","weight":0.1594},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.116},{"period":"6month","weight":-0.3701},{"period":"1year","weight":-0.644},{"period":"ytd","weight":0.0847}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cellectar Biosciences, Inc.以前名为Novelos Therapeutics, Inc.于1996年6月成立于特拉华州。2014年2月11日，公司更名为现在的名字。该公司是一家后期临床生物制药公司，专注于癌症治疗药物的发现、开发和商业化。该公司的核心目标是利用专有的磷脂醚药物偶联物递送平台开发PDC，这些PDC旨在专门针对癌细胞，并由于更少的脱靶效应而提供更好的功效和更好的安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.017624},{"month":2,"riseRate":0.666667,"avgChangeRate":0.024048},{"month":3,"riseRate":0.5,"avgChangeRate":-0.017454},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.105027},{"month":5,"riseRate":0.363636,"avgChangeRate":0.04422},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.071723},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.096298},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.013426},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.024755},{"month":10,"riseRate":0.083333,"avgChangeRate":-0.159758},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.062866},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.062943}],"exchange":"NASDAQ","name":"Cellectar Biosciences Inc.","nameEN":"Cellectar Biosciences"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cellectar Biosciences Inc.,CLRB,Cellectar Biosciences Inc.股票,Cellectar Biosciences Inc.股票老虎,Cellectar Biosciences Inc.股票老虎国际,Cellectar Biosciences Inc.行情,Cellectar Biosciences Inc.股票行情,Cellectar Biosciences Inc.股价,Cellectar Biosciences Inc.股市,Cellectar Biosciences Inc.股票价格,Cellectar Biosciences Inc.股票交易,Cellectar Biosciences Inc.股票购买,Cellectar Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cellectar Biosciences Inc.(CLRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cellectar Biosciences Inc.(CLRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}